PulseLife has acquired Invivox, bringing together clinical decision support and continuing medical education. The financial terms of the acquisition were not disclosed.
The deal connects two complementary uses around the same healthcare audience. PulseLife has over 900,000 healthcare professionals as users, and Invivox has trained nearly one million healthcare professionals. This transaction strengthens PulseLife’s ambition to build a European medical knowledge ecosystem.